Active	Status	Sponsor type	Region	Phase	Filter
6 Active 2 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
McDonald, Fiona
HALT, NCT03256981: Stereotactic Body Radiotherapy for the Treatment of OPD	Active, not recruiting	2/3	113	Europe	SBRT, Stereotactic body radiotherapy, SABR, TKI, Tyrosine Kinase Inhibitor	Institute of Cancer Research, United Kingdom	NSCLC	07/23	06/25
PRIMING, NCT03368222: Pembrolizumab and SBRT in Metastatic Non-small-cell Lung Cancer Patients	Not yet recruiting	1	24	NA	Pembrolizumab, KEYTRUDA, MK3475, Sterotactic Body Radiotherapy, SBRT	Royal Marsden NHS Foundation Trust, Merck Sharp & Dohme Corp.	Non Small Cell Lung Cancer, NSCLC, NSCLC, Stage IIIB, NSCLC Stage IV	05/21	05/21
MESO-PRIME, NCT04166734: Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma	Terminated	1	3	Europe	Pembrolizumab, Keytruda, Stereotactic Body Radiotherapy (SBRT), SBRT	Royal Marsden NHS Foundation Trust, Merck Sharp & Dohme LLC	Advanced Malignant Pleural Mesothelioma	07/23	07/23
SARON, NCT02417662: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer	Active, not recruiting	N/A	340	Europe	Radical Radiotherapy (Conventional RT and SABR), Non-investigational SACT	University College, London, Cancer Research UK	Non-small Cell Lung Cancer	08/25	08/28
PRIMALung, NCT04790253: PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients ( Study)	Recruiting	N/A	600	Europe	Prophylactic cranial irradiation	European Organisation for Research and Treatment of Cancer - EORTC, UNICANCER	Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer	04/28	04/28
ACTRN12615000761561: Truce: A pragmatic controlled trial of a seven-week Acceptance and Commitment Therapy program for young people who have a parent with cancer	Recruiting	N/A	140			CanTeen, CanTeen Australia, Australian Rotary Health	Psychological distress related to having a parent with cancer